News

Woburn, MA. – October 21, 2021 – Open Implants hired Pamela Hanneman as their Product Development and Technical Education Manager. Pamela brings with her nearly 29 years of hands-on CDT experience developing novel components for the dental industry. She is a published author, key opinion leader, and PTC trainer.
Prior to joining Open Implants, Hanneman grew multiple milling centers increasing efficiencies and profitability. In addition, Ms. Hanneman has traveled throughout North America to educate and train technicians and clinicians on material handling, improving analog and digital workflows, and standardizing operating procedures.
Gregg M. Gellman, Chief Executive Officer of Open Implants, said, “We are honored to have Pam on board. Her clinical and technical experience in conjunction with her dental component product knowledge will only serve to complement the mission of Open Implants…To bring thoughtfully designed, high quality implant components to the dental community that are designed by dental technicians for dental technicians.”
Open Implants designs solutions to help simplify lab operations, reduce costs, and increase reliability. Open Implants products are designed by a lab owner and technicians with over 50 years of combined experience.
If you would like more information on Open Implants or the recent hiring of Pamela Hanneman, please contact our team at (781) 496-3939.
Read the full press release.

WOBURN, Mass., February 3, 2021 – The Board of Directors of Open Implants LLC is pleased to announce the appointment of Gregg M. Gellman as the organization’s new Chief Executive Officer. With more than 15 years of experience, leading and growing biomedical companies, Gellman brings a unique and strong skill set to the company.
Gellman’s previous experience includes executive leadership roles at EBI Biomet, now Zimmer Biomet, Greatbatch now Integer Holdings, EnerMed now Garwood Medical, StimMed and Thinking Robot Studios where he will continue to serve as a Board Member for both companies. He has a proven track record in product development, commercialization of regulated applications/products, regulatory and sales. Gellman is a graduate of the State University of New York at Buffalo. He is certified in Quality Systems for Medical Devices (FDA’s QSR and ISO 13485) and in Global Product Submissions Directive Requirements (510(k), PMA, CE Mark).
Read the full press release.